A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
about
Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial.Nonerosive Reflux Disease (NERD) - An Update.Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.Proton pump inhibitors: potential cost reductions by applying prescribing guidelines.The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.The cost of enhanced acid suppression.Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease.Management strategies for gastroesophageal reflux disease.Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.Treatment of uncomplicated reflux diseaseReview article: gastro-oesophageal reflux disease--the health economic implications.An update on the available treatments for non-erosive reflux disease.On-demand therapy for gastroesophageal reflux disease.Current advances in the diagnosis and treatment of nonerosive reflux disease.The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.Effects of pantoprazole 20 mg in mildgastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term.Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.Acid peptic diseases: pharmacological approach to treatment.Gastro-oesophageal reflux. Part 2: medical treatment.Gastro-oesophageal reflux. Part 3: medical and surgical treatment.The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux.Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.Acid-suppressive therapy use associated with antihypertensive agents.Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.Patient selection for therapy reduction after long-term daily proton pump inhibitor treatment for gastro-oesophageal reflux disease: trial and error.Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa.
P2860
Q33411583-8FA8F5FA-2BD8-4464-890A-03112BB55F50Q33890423-C90228C4-A729-48DE-9878-D3910AEEB8A9Q34181922-15E0D987-3BE6-4691-BF29-9BBC12BA4337Q34481174-4C496555-F1AA-4B29-A25F-59B78D430008Q34541695-08F54143-28EA-414A-AF5C-14377C6379A0Q34786709-AA0B0FBA-56AC-48B3-A5D1-0A8BED26A896Q35572523-FE319FE9-BA5D-4B29-B2D5-0F97A64CE7F6Q35857847-11339CF6-BF7E-438C-8A0B-CA0A29E305C9Q35868522-3F24EB78-D184-4E1E-A5D2-F5991D51905EQ35923949-99F8ECEE-AF89-49CA-A68D-BE298CE510C6Q36204260-317B0088-60AF-4404-9E7E-E771A58C65F6Q36206570-2535E6A8-6E72-4E6F-90CF-30AF370D25C8Q36349598-4AB6BC57-4F2A-4461-B99F-BA16C8B3CE2EQ36677627-FE2DAD59-58DF-4B70-860A-06501C2BAFF2Q37051858-D2D08962-8858-4FD8-9E7D-49747C6992F2Q37140226-AB794096-4DD3-40AE-BDE4-5439BF408152Q37609380-A1DF5E47-0986-4076-8EB3-60F0AC22DE0DQ37661062-652762EB-6D51-4197-A141-781F46748CE5Q37808356-DACA75E2-D722-4B91-BEDD-42C6A5654507Q37913063-28E734D3-90B3-4323-81CA-534918C9E2F6Q38094883-23EE9836-DBE3-46BF-806B-08BA050B31ACQ38099167-0D9A67A4-C121-4118-B475-D6A84052C255Q38404870-5C9C87EF-7839-4651-81EF-A34E5B5C7F82Q39227706-F380B5F6-5DF8-4061-985F-A97185AF2683Q39367299-34BD3ABF-613D-4C4D-95FF-7E3C934F5DC3Q39378798-737D0650-2848-4BC7-90EA-E2C986A68000Q39409878-6AF322AD-C063-4033-AFE9-E3FAB22F0056Q39416473-C64267CE-4377-4521-BD38-6FE227F7A099Q40721264-B8BC7FAE-28FF-4B8C-8D18-FEBD8D811A42Q43266030-A45F0F48-A9A0-4D98-A9E2-A98A034ADCF8Q43673462-8CEFA52D-D1B9-4FF9-86A1-FFE9750E4E2DQ44299609-3BCC2163-06E7-435C-A0EE-69ED3B7A5196Q47919882-D498A69A-0B22-4225-8417-77D9368AFB49Q52935129-13825F19-3CEB-48BE-B850-C8D771BB25CC
P2860
A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A cost-effectiveness analysis ...... stroesophageal reflux disease.
@en
type
label
A cost-effectiveness analysis ...... stroesophageal reflux disease.
@en
prefLabel
A cost-effectiveness analysis ...... stroesophageal reflux disease.
@en
P2093
P2860
P1476
A cost-effectiveness analysis ...... stroesophageal reflux disease.
@en
P2093
Hornberger J
Robbins AS
Triadafilopoulos G
P2860
P304
P356
10.1111/J.1572-0241.2000.01759.X
P407
P577
2000-02-01T00:00:00Z